Table 2.
Hematology characteristics of study participants before and after breakthrough infection.
| BBIBP-CorV (n = 25) | ZF2001 (n = 13) | |||||
|---|---|---|---|---|---|---|
| Pre | Post | p_Value | Pre | Post | p_Value | |
| WBC (109/L) | 5.78 (5.36–6.61) | 6.01 (4.92–7.45) | 0.380 | 4.06 (3.95–5.58) | 4.80 (3.85–5.77) | 0.339 |
| HGB (g/L) | 155 (147–163) | 153 (146–161) | 0.025 * | 155 (143–162) | 151 (146–162) | 0.537 |
| PLT (109/L) | 250 (206–300) | 242 (217–287) | 0.864 | 218 (197–255) | 230 (202–253) | 0.201 |
| CRE (µmol/L) | 87 (82–91) | 85 (80–89) | 0.035 * | 78 (76–81) | 81 (75–92) | 0.275 |
| ALT (U/L) | 25 (19–34) | 25 (19–48) | 0.079 | 30 (26–35) | 27 (23–34) | 0.735 |
| AST (U/L) | 23 (22–28) | 23 (21–33) | 0.255 | 28 (25–30) | 25 (22–28) | 0.572 |
| GGT (U/L) | 39 (26–58) | 48 (25–73) | 0.231 | 31 (27–49) | 36 (30–48) | 0.420 |
| GLU (mmol/L) | 5.3 (5.1–5.6) | 5.3 (4.9–5.8) | 0.579 | 5.2 (5.1–6.6) | 5.1 (5.0–6.8) | 0.243 |
| TG (mmol/L) | 1.57 (0.84–2.38) | 1.41 (1.14–2.09) | 0.484 | 1.92 (1.23–2.56) | 1.73 (1.11–2.54) | 0.599 |
| TC (mmol/L) | 4.20 (3.89–4.58) | 4.13 (3.67–4.70) | 0.833 | 4.44 (4.30–4.80) | 4.38 (4.19–4.67) | 0.290 |
| GLO (g/L) | 26 (24–29) | 26 (23–28) | 0.931 | 25 (23–27) | 26 (23–29) | 0.948 |
Data are shown as median (interquartile range). The asterisk represents the presence of significance. WBC, white blood cell count; HGB, hemoglobin; PLT, platelet count; CRE, creatinine; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, γ-glutamyl transpeptidase; GLU, blood glucose; TG, triglyceride; TC, total cholesterol; GLO, globulin.